| Nuvectra is a neurostimulation medical device company focused on the development and commercialization of its neurostimulation technology platform for the treatment of various disorders through stimulation of tissues associated with the nervous system. Co.'s neurostimulation technology platform has the potential to provide treatment to patients in several neurostimulation markets, including spinal cord stimulation (SCS), sacral neuromodulation, deep brain stimulation, and other emerging neurostimulation markets. Co.'s Algovita® SCS system (Algovita), is an application of its neurostimulation technology platform and is indicated for the treatment of chronic pain of the trunk and/or limbs. We show 15 historical shares outstanding datapoints in our NVTR shares outstanding history coverage, used to compute NVTR market cap on those dates.|
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing NVTR market cap history over the course of time is important for investors
interested in comparing NVTR's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of NVTR versus a peer is one thing; comparing
NVTR market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like NVTR can fluctuate over the course of history.
With this page we aim to empower investors researching NVTR by allowing them to research the NVTR market cap history.